NCT02104479View on ClinicalTrials.gov

Diagnostic Accuracy of Pleural Effusion Aspergillosis Biomarker Testing

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Invasive AspergillosisPleural EffusionImmunosuppression
Trial Locations (2)

68167

University Hospital Mannheim, Mannheim

97080

Wuerzburg University Hospital, Würzburg

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Heidelberg University

OTHER